ReviewClinical and translational allergy2017
European Summit on the Prevention and Self-Management of Chronic Respiratory Diseases: report of the European Union Parliament Summit (29 March 2017).
Review in Clinical and translational allergy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 75 citations in OpenAlex.
- Review
- EUFOREA summit in Brussels 2025: inspiring the future of allergy and respiratory care.Frontiers in allergy · 2026Article
- Raising the bar in respiratory care by EUFOREA: report of the European Union Parliament Symposium, April 2024.Frontiers in allergy · 2025Article
- ULANC - EUFOREA workshop 2024: bringing the concept of global airways to the frontline of medical care.Frontiers in allergy · 2025Article
- EUFOREA meeting on defining disease states in allergic rhinitis: towards a unified language in AR.Frontiers in allergy · 2024Article
- Chronic Obstructive Pulmonary Disease: Lifestyle Impact.International journal of preventive medicine · 2024Review
- European biologic training course for type 2 inflammation by EUFOREA in 2024: key facts and lessons learned.Frontiers in allergy · 2024Article
- Multivariate time-series sensor vital sign forecasting of cardiovascular and chronic respiratory diseases.Sustainable computing : informatics and systems · 2023Article
- EUFOREA summit in Brussels 2023:Frontiers in allergy · 2023Article
- Digital tools in allergy and respiratory care.The World Allergy Organization journal · 2022Review
- White Paper on European Patient Needs and Suggestions on Chronic Type 2 Inflammation of Airways and Skin by EUFOREA.Frontiers in allergy · 2022Article
- On the role of allergen-specific IgG subclasses for blocking human basophil activation.Frontiers in immunology · 2022Article
- Defining an enabling environment for those with chronic disease: an integrative review.BMC nursing · 2021Article
- A Machine-Learning-Based System for Prediction of Cardiovascular and Chronic Respiratory Diseases.Journal of healthcare engineering · 2021Article
- Patients Unmet Needs in Chronic Rhinosinusitis With Nasal Polyps Care: A Patient Advisory Board Statement of EUFOREA.Frontiers in allergy · 2021Article
- Real-life assessment of chronic rhinosinusitis patients using mobile technology: The mySinusitisCoach project by EUFOREA.Allergy · 2020Article
- Epithelial barriers in allergy and asthma.The Journal of allergy and clinical immunology · 2020Review
- ARIA 2019, Allerjik Rinite Tedavi Yaklaşımı-Türkiye.Turkish thoracic journal · 2020Review
- Aligning the Good Practice MASK With the Objectives of the European Innovation Partnership on Active and Healthy Ageing.Allergy, asthma & immunology research · 2020Review
- Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 2).Journal of thoracic disease · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors at 17 institutions in 11 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
On March 29, 2017, a European Summit on the Prevention and Self-Management of Chronic Respiratory Diseases (CRD) was organized by the European Forum for Research and Education in Allergy and Airway Diseases. The event took place in the European Parliament of Brussels and was hosted by MEP David Borrelli and MEP Sirpa Pietikainen. The aim of the Summit was to correspond to the needs of the European Commission and of patients suffering from CRD to join forces in Europe for the prevention and self-management. Delegates of the European Rhinologic Society, European Respiratory Society, European Academy of Allergy and Clinical Immunology, European Academy of Paediatrics, and European Patients Organization EFA all lectured on their vision and action plan to join forces in achieving adequate prevention and self-management of CRD in the context of Precision Medicine. Recent data highlight the preventive capacity of education on optimal care pathways for CRD. Self-management and patient empowerment can be achieved by novel educational on-line materials and by novel mobile health tools enabling patients and doctors to monitor and optimally treat CRDs based on the level of control. This report summarizes the contributions of the representatives of different European academic stakeholders in the field of CRD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.